

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Ko te Daclizumab he rongoā rongoā i whakamahia hei rongoā i te sclerosis maha (MS) mā te whakaiti i te mumura i roto i te roro me te taurakira. I mahi tēnei rongoā mā te aukati i ngā tohu punaha ārai mate motuhake e whai wāhi ana ki ngā whakaeke MS.
Heoi, i tangohia noa te daclizumab mai i te mākete i te tau 2018 nā te mea he nui ngā āwangawanga haumaru. Ahakoa i whakaatu i te oati ki te rongoā MS, i puta ngā raruraru ate onge engari nui i arahi ki tōna whakamutunga puta noa i te ao.
Ko te Daclizumab he rongoā koiora i hangaia motuhake hei rongoā i ngā momo hoki mai o te sclerosis maha. I noho ia ki tētahi akomanga rongoā e kiia nei ko ngā paturopi monoclonal, he pūmua i hangaia i te taiwhanga e whai ana i ngā wāhanga motuhake o tō punaha ārai mate.
I tukuna te rongoā hei werohanga ia marama i raro i te kiri, i te nuinga o te wā i tō huha, puku, i te ringa rānei o runga. I hokohoko ia i raro i te ingoa waitohu Zinbryta, ā, i whakaarohia he rongoā tuarua mō ngā tūroro MS kāore i pai te urupare ki ētahi atu rongoā.
Kāore i rite ki ētahi rongoā MS e pēhi whānui ana i tō punaha ārai mate, i mahi te daclizumab i te kōwhiri. I whāia e ia tētahi pūmua motuhake e kiia nei ko CD25 i runga i ētahi pūtau ārai mate, me te whai ki te whakaiti i ngā whakaeke ārai-aunoa e whakangaro ana i ngā muka io i roto i te MS.
I te tuatahi i tohua te Daclizumab mō ngā pakeke e hoki mai ana ngā momo o te sclerosis maha. Kei roto i tēnei ko te hoki mai-whakawātea MS me te tuarua o te MS haere tonu me ngā hokinga mai, ngā āhuatanga e pā ana ki ngā tūroro e pā ana ki ngā wā o ngā tohu hou e whai ana i te whakaora wāhanga, oti rānei.
Kua whakaaro pea tō tākuta ki te daclizumab mēnā he maha āu hokinga mai MS ahakoa te whakamahi i ētahi atu rongoā whakarerekē i te mate. I te nuinga o te wā i rahuitia mō ngā tūroro i pā ki te mahi mate i runga i ngā rongoā rārangi tuatahi pēnei i te interferons, glatiramer acetate rānei.
Kāore i whakaaetia te rongoā mō te MS haere tonu tuatahi, e kaha haere ana ngā tohumate me te kore o ngā hokinga mai. Kāore hoki i tika mō ngā tūroro e pā ana ki ētahi āhuatanga ate, ki te hunga rānei e tūpono ana ki ngā raruraru ate.
I mahi a Daclizumab mā te aukati i tētahi kaiwhakawhiwhi motuhake e kīia ana ko CD25 i runga i ngā pūtau T kua whakahohehia, he pūtau toto mā e whai wāhi nui ana ki ngā whakaekenga aunoa. Mā te aukati i tēnei kaiwhakawhiwhi, i aukati te rongoā i ēnei pūtau ārai mate kino mai i te whakanui me te whakaeke i ngā kiko io hauora.
Whakaarohia me te mea e whakatakoto ana koe i tētahi raka ki te tatau e whakamahia ana e ngā pūtau mumura ki te uru ki tō roro me tō taurakira. I te wā i aukati a daclizumab i te kaiwhakawhiwhi CD25, i whakanuia hoki te maha o ngā pūtau kaikōhuru tūturu, nā te mea i āwhina i te whakahaere i te urupare ārai mate kia whai hua ake.
Nā tēnei huarahi whāinga i kaha ai a daclizumab ki te whakataurite ki ētahi atu rongoā MS. He mea motuhake ake i ngā rongoā ārai mate whānui engari me mātakitaki tonu i te tūponotanga ki ōna pānga ki te mahi o te pūnaha ārai mate.
I whakahaerea a Daclizumab hei werohanga i raro i te kiri kotahi ia whā wiki. Ko te horopeta paerewa he 150 mg, i tukuna mā te syringe kua whakakiia i mua i te wā, māu, mā tētahi kaiwhakarato hauora rānei e werohia i raro i tō kiri.
I huri ngā wāhi werohanga i waenga i tō huha, puku, i tō ringa rānei kia kore ai e riri te kiri. Ka taea e koe te tango i te rongoā me te kore kai rānei, nā te mea kāore te kai i pā ki te āhua o te tango o tō tinana i te rongoā.
I mua i te tīmatanga o te maimoatanga, ka whakamātautau toto tō tākuta ki te tirotiro i te mahi o tō ate. I haere tonu te mātakitaki i te wā o te maimoatanga, me te whakamātautau toto i te nuinga o te wā i ia marama ki te mātakitaki i ngā tohu o ngā raruraru ate.
Me penapena te rongoā i roto i tō pouaka whakamātao, me te kawe ki te pāmahana rūma i mua i te werohanga. I tae mai ia horopeta i roto i te syringe kotahi-whakamahi kua whakakiia i mua i te wā, me whakakore e koe i te haumaru i muri i te whakamahi.
I rereke te roa o te maimoatanga daclizumab i runga i te pai o to urupare ki te rongoa me te mea i pa ki a koe etahi paanga taha. Ko te nuinga o nga turoro i whai hua mai i te maimoatanga i haere tonu mo te wa roa, na te mea ka mutu ka hoki ano te mahi MS.
Ka arotakehia e to taakuta to urupare i nga wa katoa ma nga karapa MRI me nga whakamatautau neurological, i te nuinga o te wa ia 6 ki te 12 marama. Mena i pa ki a koe nga hokinga hou, i te kino ranei o te hauatanga ahakoa te maimoatanga, ka whakaaro pea to taakuta ki te huri ki tetahi rongoa MS rereke.
Heoi, ka mutu tonu te maimoatanga mena ka puta nga tohu o nga raruraru ate, penei i te kowhai o to kiri, o ou kanohi ranei, te mimi pouri, te whakapairuaki tonu ranei. I te mutunga ka tangohia te rongoa mai i te maakete na enei awangawanga haumaru e pa ana ki te ate.
Ka taea e Daclizumab te maha o nga paanga taha, mai i te ngawari ki te kaha. Ko te mohio ki enei tauhohenga ka awhina i nga turoro me nga taakuta ki te whakatau i nga whakatau maimoatanga me te aro turuki i nga tohu e pa ana.
Ko nga paanga taha tino noa he mea whakahaere, a ko enei:
Ko nga paanga taha nui ake me whai wawe tonu te rongoa, tae atu ki nga raruraru ate nui, ka mate pea. Ko enei take ate te take tuatahi i tangohia ai te rongoa mai i te maakete.
Ko nga raruraru onge engari nui ko:
Ko ēnei pānga kino, otirā ngā raruraru ate, i puta i roto i te iti o te hunga tūroro engari ka mate. Nō reira i tangohia noa a daclizumab i ngā mākete katoa o te ao.
Kāore a Daclizumab i tika mō te katoa e mate ana i te sclerosis maha. Ko ētahi āhuatanga hauora me ngā āhuatanga i hanga ai te rongoā kia mōrearea rawa atu, kia kore e tika mō te whakamahi.
Kāore koe i tika kia tango i te daclizumab mēnā i a koe:
I hiahiatia te tūpato motuhake mō ngā tūroro he hītori o te pōuri, ngā āhuatanga ārai-a-tinana i tua atu i te MS, ērā rānei e tango ana i ētahi atu rongoā ka pā ki te ate. Ka āta arotake tō tākuta i tō hītori hauora i mua i te whakahau i te daclizumab.
Kāore hoki te rongoā i tūtohutia mō ngā tūroro neke atu i te 65 tau te pakeke, i te mea he iti ngā raraunga haumaru i roto i tēnei rōpū tau. I tohutohutia ngā whaea e whāngai ana i te u kia karo i te rongoā nā te mōrearea pea ki te pēpi.
I hokohoko a Daclizumab i raro i te ingoa waitohu Zinbryta mō te rongoā sclerosis maha. Koinei te ingoa arumoni tuatahi i whakamahia i te United States, Europe, me ētahi atu whenua i whakaaetia ai.
I mua i tōna whanaketanga, i mōhiotia hoki te daclizumab i raro i te ingoa waitohu Zenapax i te wā i whakamahia ai hei ārai i te whakakāhore i ngā whakawhitinga okana. Heoi, he rerekē tēnei hanganga i te putanga MS, ā, i whakamutua hoki.
Mai i te wā i tangohia ai te rongoā mai i te mākete, kāore anō a Zinbryta i te wātea mā tētahi whare rongoā, kaiwhakarato hauora rānei. Ko ngā tūroro i tango i tēnei rongoā kua whakawhitia ki ngā rongoā MS kē.
Mai i te wā kāore anō a daclizumab i te wātea, he maha atu ngā rongoā whakarerekē i te mate ka taea te rongoā i ngā momo o te multiple sclerosis e hoki mai ana. Ka taea e tō tākuta te āwhina i a koe ki te kimi i te kōwhiringa e tika ana i runga i tō āhuatanga motuhake.
Kei roto i ngā kōwhiringa o nāianei:
He pai me ngā tūponotanga anō tō ia kōwhiringa, ā, ka whakaaro tō tākuta i ngā āhuatanga pēnei i tō mahi mate, ngā rongoā o mua, me tō hītori hauora whaiaro. Ko te whāinga he kimi i tētahi rongoā e whakahaere ana i tō MS i te wā e whakaiti ana i ngā pānga taha.
He maha ngā tūroro i tango i te daclizumab kua angitu te whakawhiti ki ētahi atu rongoā me te whakahaere tonu i te mate. Ka mahi tō rōpū hauora i te taha tata ki a koe kia mōhio ai he pai te whakawhiti me te whakahaere tonu i tō MS.
I whakaatu a Daclizumab i te whai hua i roto i ngā whakamātau haumanu i te whakataurite ki te interferon beta-1a, e whakaiti ana i ngā reiti hoki mai me ngā whara roro hou i roto i te maha o ngā tūroro. Heoi, ko tōna āhua haumaru kino i te mutunga i nui ake i ēnei painga.
I whakaatu ngā rangahau he kaha ake te daclizumab i ētahi rongoā rārangi tuatahi ki te whakaiti i te kaha o te mate. He iti ake te maha o ngā tūponotanga o te hunga tūroro, me te iti ake o te piki haere o te hauātanga i te hunga e whakamahi ana i ngā rongoā interferon.
Ahakoa te whai hua, ko te tangohanga o te rongoā i te mākete nā te āwangawanga mō te haumaru o te ate, ko te tikanga kāore anō i te whakaarohia he kōwhiringa whai hua. Ko ngā rongoā MS o nāianei pēnei i te ocrelizumab, i te natalizumab rānei, ka whai hua pea, he pai ake rānei, me ngā āhuatanga haumaru e ngāwari ana te whakahaere.
Kua tino huri te āhua o te rongoā MS mai i te tangohanga o te daclizumab. He maha ngā rongoā hou e whakarato ana i te mana whakahaere pai mō te mate me ngā āhuatanga o ngā pānga taha e mōhiotia ana, e ngāwari ana te whakahaere, e pai ake ai te kōwhiringa mō te nuinga o ngā tūroro.
Kāore, kāore i te haumaru te daclizumab mō te hunga e raru ana te ate. Ka taea e te rongoā te pā mai i te mumura nui o te ate me te kino, koinei te take nui i tangohia ai i te mākete.
Ahakoa te hunga tūroro he pai te mahi o te ate, me mātakitaki ia marama mō ngā raru o te ate i te wā e whakamahi ana i te daclizumab. Ko te hunga he hītori mate ate kāore i te tika mō tēnei rongoā nā te pikinga o te tūponotanga o ngā raruraru e mōrearea ana te ora.
Mēnā i whiwhi koe i te nui ake i te horopeta i whakaritea o te daclizumab, whakapā atu ki tō tākuta, ki ngā ratonga ohorere rānei tonu. Ka taea e te horopeta nui te whakanui i te tūponotanga o ngā pānga taha nui, ina koa ko ngā raru o te ate me ngā mate nui.
Kāore he rongoā motuhake mō te horopeta nui o te daclizumab, nō reira i arotahi te rongoā ki te whakahaere i ngā tohumate me te mātakitaki mō ngā raruraru. Ka nui ake pea te auau o ngā whakamātautau toto e tō tākuta ki te mātakitaki mō ngā raru o te ate me ētahi atu pānga taha nui.
Mēnā i ngaro koe i tō werohanga daclizumab ia marama, whakapā atu ki tō kaiwhakarato hauora i te wa e taea ai ki te whakarite anō. I whakawhirinaki te whai huatanga o te rongoā ki te pupuri i ngā taumata rite tonu i roto i tō pūnaha.
Ka whakatau tō tākuta i te wā pai mō tō horopeta e whai ake nei i runga i te roa o te wā mai i tō werohanga whakamutunga. I te nuinga o te wā, ka whiwhi koe i te horopeta i ngaro i te wā e taea ai, ā, ka haere tonu koe i tō rārangi ia marama.
Mai i te mea kua tangohia te daclizumab i te mākete, kua mutu kē ngā tūroro katoa te tango i tēnei rongoā. I whakatinanahia te tangohanga i runga i ngā āwangawanga haumaru, inā koa ngā raruraru ate nui ka mōrearea ai te ora.
Mēnā i tango koe i te daclizumab i mua, ka āwhina tō tākuta i a koe ki te huri ki tētahi atu rongoā MS. Ko te whakamutu i ngā rongoā MS katoa e hiahia ana kia tino mātakitaki te rongoā kia kore ai e hoki mai te mate me te whakarite kia mau tonu te whakamarumaru.
Kāore i tūtohutia te Daclizumab i te wā e hapū ana i runga i ngā mōrearea ka pā ki te pēpi e whanake ana. Ka pā te rongoā ki te whanaketanga o te pūnaha ārai mate o te pēpi, ā, ka puta pea ngā raruraru.
I tohutohutia ngā wāhine o te tau whānau e tango ana i te daclizumab kia whakamahi i te aukati hapū whai hua i te wā e rongoā ana me ngā marama maha i muri i te whakamutu. Mēnā ka hapū i te wā e tango ana i te rongoā, he mea nui te kōrero tonu ki ngā kaiwhakarato hauora ki te aromatawai i ngā mōrearea me ngā painga.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.